Skip to content

Study · Not a test of the peptide alone · 2001

4 results

[Cerebrovascular and renal effects of cerebrolysin and dependence on salt intake].

Sadin AV, Shtrygol' SIu

Eksperimental'naia i klinicheskaia farmakologiia1 Nov 2001Cited by 1 (Europe PMC)

PMID11871236 (opens in a new tab)PepBankPUB-11871236

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with carotid occlusion, Cerebrolysin efficacy was less pronounced under a high-Na diet.

    In plain wordsIn rats with carotid occlusion, Cerebrolysin had less pronounced effects under a high-Na diet.

    Outcome
    DecreaseCerebrolysin efficacy under high sodium intake
    Study

    ratn: not reported in source

    Common carotid artery occlusion
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    In the test animals receiving a high-Na diet, the efficacy of cerebrolysine was less pronounced.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with carotid occlusion, hyposol increased the antiischemic effect of Cerebrolysin.

    In plain wordsIn rats with carotid occlusion, hyposol increased the effect of Cerebrolysin against ischemia.

    Outcome
    IncreaseAntiischemic effect with hyposol
    Study

    ratn: not reported in source

    Common carotid artery occlusion
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    In contrast, hyposol increased the antiischemic, saluretic and antiswelling effects of cerebrolysine under the carotid artery occlusion.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 03AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with carotid occlusion, hyposol increased the saluretic effect of Cerebrolysin.

    In plain wordsIn rats with carotid occlusion, hyposol increased the salt-excretion effect of Cerebrolysin.

    Outcome
    IncreaseSaluretic effect with hyposol
    Study

    ratn: not reported in source

    Common carotid artery occlusion
    Outcome group
    Kidney function · Kidney and urinary

    Source sentences

    Summary
    In contrast, hyposol increased the antiischemic, saluretic and antiswelling effects of cerebrolysine under the carotid artery occlusion.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  4. 04AnimalNot a test of Cerebrolysin aloneAnimal study (in vivo)Efficacy outcome

    In rats with carotid occlusion, hyposol increased the antiswelling effect of Cerebrolysin.

    In plain wordsIn rats with carotid occlusion, hyposol increased the effect of Cerebrolysin against swelling.

    Outcome
    IncreaseAntiswelling effect with hyposol
    Study

    ratn: not reported in source

    Common carotid artery occlusion
    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    In contrast, hyposol increased the antiischemic, saluretic and antiswelling effects of cerebrolysine under the carotid artery occlusion.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.